Cellulis has been granted funds from a Spanish RETOS consorcium
Cellulis has been granted funds from a Spanish RETOS consorcium to further develop Limbo™ cryopreservation platform for CAR-T cells.
- Cellulis has been granted funds from a Spanish RETOS consorcium Tuesday, July 31, 2018 - 14:33
- Cellulis strikes another Seal of Excellence Friday, June 15, 2018 - 12:28
- CELLULIS TECHNOLOGY LIMBO™ HAS BEEN GRANTED A US PATENT Friday, May 5, 2017 - 14:23